Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds RSS Feed PharmiWeb Candidate Blog RSS Feed PharmiWeb Client Blog

Partnering With Jooble


The Latest Pharma Jobs, News and Events today | 08 December 2016

Good Start Genetics Announces Marketing Agreement with Roche Diagnostics for Carrier Screening in the United States

Good Start Genetics, an information solutions company delivering best-in-class genetics offerings to growing families, today announced that it has entered into a collaborative agreement with global healthcare leader Roche (SIX: RO, ROG; OTCQX: RHHBY) to sell Good Start's carrier screening service for inherited genetic disorders. Under the agreement, Roche Diagnostics will offer Good Start Genetics' GeneVu™ carrier screening test service in conjunction with its Harmony™ non-invasive prenatal test (NIPT) service to obstetricians and general practitioners caring for pregnant women in the United States. ...

"We are excited to announce our collaboration with Roche Diagnostics to address the significant market need for prenatal carrier screening utilizing our proprietary next generation sequencing technology platform," said Jeffrey Luber, President and CEO of Good Start Genetics. "It is an honor to team up with a world-class organization like Roche as we address a significant unmet need.  Offering GeneVu, our comprehensive and highly accurate carrier screening test service for inherited genetic disorders, with Roche's Harmony NIPT service, which assesses the risk of fetal trisomy 21, 18, 13, and sex chromosome aneuploidy, provides the 20,000+ OBGYNs in the United States with two best-in-class solutions for their expectant moms."

As the nation's leading medical organization for women's health, the American College of Obstetricians and Gynecologists (ACOG) recommends that the more than 60 million women of reproductive age in the U.S. be offered genetic testing for cystic fibrosis (CF), while the American College of Medical Genetics and Genomics (ACMG) recommends screening for both CF and spinal muscular atrophy. The GeneVu test service offers screening for these inherited genetic conditions and others.

"The agreement with Good Start Genetics will enable Roche to offer a broader range of screening services to healthcare professionals who provide care for pregnant women and for parents involved in planning a family," said Whitney Green, Senior Vice President, Commercial Operations for Roche Diagnostics. "Good Start's GeneVu service is an innovative test that will complement our Harmony prenatal test service to allow prospective parents to confidently assess the risk of various genetic conditions in themselves and in the child."

show more

Latest Poll

Are you worried that Brexit will be bad for UK Pharma Jobs?


Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.